This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Salion Gmbh. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Michael Marzinzig: Innovator in Early Detection Methods
Introduction
Michael Marzinzig, an accomplished inventor based in Ulm, Germany, is known for his significant contributions to the field of medical diagnostics. With one patented innovation under his belt, he is dedicated to improving early detection methods for various health conditions.
Latest Patents
Marzinzig's notable patent centers around an in vitro method for the early detection of potential inflammation. This method is particularly useful for identifying issues associated with transplant rejection, neurodegenerative disorders, or depression. The patent details a test that determines the level of kynurenine in saliva, making it a straightforward and non-invasive means of identifying potential health problems. This innovation demonstrates a commitment to advancing medical diagnostics and patient care.
Career Highlights
Currently, Michael Marzinzig is associated with Salion GmbH, where he continues to engage in groundbreaking research and development. His work not only enhances diagnostic approaches but also sets the stage for future innovations in healthcare technology. Marzinzig's expertise in medical inventions highlights his role as a key player in the ongoing efforts to improve health outcomes through scientific advancement.
Collaborations
In his professional journey, Marzinzig has had the opportunity to collaborate with notable colleagues such as Dietmar Abendroth and Manfred J. Stangl. These collaborations have likely contributed to the richness of ideas and innovation reflected in his work.
Conclusion
Michael Marzinzig stands out as a pioneering inventor who is making strides in medical diagnostics through his innovative patent. His dedication to improving early detection methods holds great promise for enhancing healthcare practices, benefiting both patients and medical professionals alike. As he continues to work with Salion GmbH and collaborate with talented individuals, his future contributions to the field of medical science are anticipated with great interest.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile